JAAD Case Reports (Mar 2018)

Generalized morphea/eosinophilic fasciitis overlap after epoxy exposure

  • Warren H. Chan, MS,
  • Daniel J. Lewis, BA,
  • Esther J. Kim, BA,
  • Phyu P. Aung, MD,
  • Madeleine Duvic, MD

DOI
https://doi.org/10.1016/j.jdcr.2017.09.006
Journal volume & issue
Vol. 4, no. 2
pp. 175 – 178

Abstract

Read online

Generalized morphea is associated with epoxy resin vapors and is characterized by the development of lesions shortly after exposure. Morphea presenting along with eosinophilic fasciitis (EF), or morphea/EF overlap, is rare and an indicator of poor prognosis and resistance to treatment. Here we present a case of generalized morphea/EF overlap linked to epoxy exposure. Our patient received multiple therapies—ultraviolet A1 phototherapy, prednisone, methotrexate, azathioprine, mycophenolate mofetil, cyclophosphamide, cyclosporine, and rituximab—none of which led to a significant response. The refractory nature of this disease warrants vigilance in its association with epoxy exposure.

Keywords